CLB Stock Overview
Provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Narratives bring a range of perspectives from our community.
Core Laboratories Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$16.85 |
52 Week High | US$25.13 |
52 Week Low | US$13.82 |
Beta | 2.38 |
1 Month Change | -20.82% |
3 Month Change | -12.15% |
1 Year Change | -7.26% |
3 Year Change | -27.53% |
5 Year Change | -64.09% |
Change since IPO | 461.67% |
Recent News & Updates
Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture
Dec 09Is Core Laboratories (NYSE:CLB) Using Too Much Debt?
Nov 12Recent updates
Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture
Dec 09Is Core Laboratories (NYSE:CLB) Using Too Much Debt?
Nov 12Is Core Laboratories Inc. (NYSE:CLB) Trading At A 38% Discount?
Sep 19What You Can Learn From Core Laboratories Inc.'s (NYSE:CLB) P/E
Aug 14We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt
Jul 15These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong
Jun 25It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year
May 02Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?
Mar 26Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price
Mar 02Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts
Nov 09Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture
Sep 08Core Laboratories: 'Spooked The Herd' In June, Things Might Be Looking Up
Aug 16Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors
Jul 05The Returns On Capital At Core Laboratories (NYSE:CLB) Don't Inspire Confidence
May 25Shareholder Returns
CLB | US Energy Services | US Market | |
---|---|---|---|
7D | -13.3% | -6.9% | -2.4% |
1Y | -7.3% | -14.6% | 23.3% |
Return vs Industry: CLB exceeded the US Energy Services industry which returned -14.6% over the past year.
Return vs Market: CLB underperformed the US Market which returned 23.3% over the past year.
Price Volatility
CLB volatility | |
---|---|
CLB Average Weekly Movement | 7.1% |
Energy Services Industry Average Movement | 6.5% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CLB has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CLB's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1936 | 3,500 | Larry Bruno | www.corelab.com |
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Core Laboratories Inc. Fundamentals Summary
CLB fundamental statistics | |
---|---|
Market cap | US$791.11m |
Earnings (TTM) | US$26.20m |
Revenue (TTM) | US$522.82m |
30.2x
P/E Ratio1.5x
P/S RatioIs CLB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLB income statement (TTM) | |
---|---|
Revenue | US$522.82m |
Cost of Revenue | US$415.84m |
Gross Profit | US$106.98m |
Other Expenses | US$80.79m |
Earnings | US$26.20m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.56 |
Gross Margin | 20.46% |
Net Profit Margin | 5.01% |
Debt/Equity Ratio | 54.5% |
How did CLB perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield7%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:07 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Core Laboratories Inc. is covered by 44 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Robert Jan Vos | ABN AMRO Bank N.V. |
James West | Barclays |
Saurabh Pant | BofA Global Research |